RATIONALE: To compare severity of atopic dermatitis based on our institution's clinical scoring system for atopic dermatitis (CSAD) with ECP and IgE levels. METHODS: Data on 20 patients with AD was collected. The severity of disease was scored using CSAD, which includes assessment of three items (1) subjective score (quality of life), (2) objective score (type and extent of lesions) and (3) exacerbation score (based on use of rescue medication). AD was classified into four grades, mild (I), moderate (II) severe (III), and extremely severe (IV). Severity was compared with four levels of ECP level I(1-20), level II(21-40), level III(41-60) and level IV(>60).Comparison was also done with four levels of serum IgE. Level I (100-1000)), level II (>1000-5000), level III (>5000-10000) and level IV (>10,000). RESULTS: (i) 3 patients were placed in mild, 6 in moderate, 6 in severe and 5 in extremely severe categories. (ii) 6 patients had ECP at level I, 4 at level II, 7 at level III and 3 were placed in level IV category. (iii) 3 patients had serum IgE at level I, 4 at level II,7 at level III and 6 were placed in level IV category.(iv) There was no correlation between the clinical severity score , ECP and serum IgE levels. CONCLUSIONS: Our data indicate that basic clinical scoring remains a most effective method of recording skin activity in AD. A larger patient sample may needed to clarify the relation between severity of atopic dermatitis, ECP and serum IgE 416 Is Maternal History of Asthma, Atopic Dermatitis, Food Aller-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.